Publications by authors named "Garrett Nichols"

Claim this Profile
R
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell Transplantation.
Guang-Shing Cheng, Angela P Campbell, Hu Xie, Chikara Ogimi, Alpana Waghmare, W Garrett Nichols

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.
Patrick Y Wen, Andrea Manzanera, Caroline Duault, Edgar Gonzalez-Kozlova, Lenika Lopez, Garrett Nichols

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Vance G Fowler, Anita F Das, Joy Lipka-Diamond, Jane E Ambler, Raymond Schuch, W Garrett Nichols

Clin Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
Genovefa A Papanicolaou, Christopher C Dvorak, Sanjeet Dadwal, Gabriela Maron, Vinod K Prasad, Garrett Nichols

Transpl Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Joshua A Hill, W Garrett Nichols, Francisco M Marty, Genovefa A Papanicolaou, Thomas M Brundage

Blood· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
Hannah Imlay, Hu Xie, Wendy M Leisenring, Elizabeth R Duke, Louise E Kimball, W Garrett Nichols

Blood Adv· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study.
Marco Zecca, Robert Wynn, Jean-Hugues Dalle, Tobias Feuchtinger, Enrikas Vainorius, Garrett Nichols

Bone Marrow Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study.
Petr Sedláček, Toni Petterson, Marie Robin, Ponni Sivaprakasam, Enrikas Vainorius, Garrett Nichols

Biol Blood Marrow Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.
Marta González-Vicent, Marta Verna, Cécile Pochon, Aastha Chandak, Enrikas Vainorius, Garrett Nichols

Eur J Haematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
Francisco M Marty, Drew J Winston, Roy F Chemaly, Kathleen M Mullane, Tsiporah B Shore, W Garrett Nichols

Biol Blood Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation.
Joshua A Hill, Bryan T Mayer, Hu Xie, Wendy M Leisenring, Meei-Li Huang, Garrett Nichols

Clin Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox.
Greg Chittick, Marion Morrison, Thomas Brundage, W Garrett Nichols

Antiviral Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.
Joshua A Hill, Bryan T Mayer, Hu Xie, Wendy M Leisenring, Meei-Li Huang, Garrett Nichols

Blood· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
Per Ljungman, Michael Boeckh, Hans H Hirsch, Filip Josephson, Jens Lundgren, Garrett Nichols

Clin Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL.
Louise E Kimball, Terry Stevens-Ayers, Margaret L Green, Hu Xie, Mary E D Flowers, W Garrett Nichols

Contemp Clin Trials Commun· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.
Thomas H Price, Michael Boeckh, Ryan W Harrison, Jeffrey McCullough, Paul M Ness, W Garrett Nichols

Blood· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.
Dipen A Patel, Sonya J Snedecor, Wing Yu Tang, Lavanya Sudharshan, Jessica W Lim, Garrett Nichols

PLoS One· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials.
François Raffi, Anita Rachlis, Cynthia Brinson, Keikawus Arasteh, Miguel Górgolas, W Garrett Nichols

AIDS· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.
Michael Boeckh, W Garrett Nichols, Roy F Chemaly, Genovefa A Papanicolaou, John R Wingard

Ann Intern Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
Antonella Castagna, Franco Maggiolo, Giovanni Penco, David Wright, Anthony Mills, Garrett Nichols

J Infect Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Sharon L Walmsley, Antonio Antela, Nathan Clumeck, Dan Duiculescu, Andrea Eberhard, Garrett Nichols

N Engl J Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalent polymorphisms in wild-type HIV-1 integrase are unlikely to engender drug resistance to dolutegravir (S/GSK1349572).
Cindy Vavro, Samiul Hasan, Heather Madsen, Joseph Horton, Felix DeAnda, Garrett Nichols

Antimicrob Agents Chemother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing a theoretical risk of dolutegravir-induced developmental immunotoxicity in juvenile rats.
Melissa Rhodes, Susan Laffan, Caroline Genell, Jill Gower, Curtis Maier, Garrett Nichols

Toxicol Sci· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.
María J Pérez-Elías, María Larrousse Morellon, Enrique Ortega, José Hernández-Quero, Maribel Rodríguez-Torres, Garrett Nichols

Antimicrob Agents Chemother· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
Jean-Michel Molina, Mounir Ait-Khaled, Roberto Rinaldi, Giovanni Penco, Jean-Guy Baril, W Garrett Nichols

J Antimicrob Chemother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis